• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.03% Nasdaq Up 0.33%

    AcelRx Pharmaceuticals, Inc. (ACRX)

    -NasdaqGM
    4.12 Up 0.11(2.74%) Jul 30, 4:00PM EDT
    Add to Portfolio
    Prev Close:4.01
    Open:4.02
    Bid:3.25 x 3000
    Ask:4.25 x 1000
    1y Target Est:5.50
    Beta:3.31
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:4.01 - 4.18
    52wk Range:2.96 - 9.32
    Volume:549,840
    Avg Vol (3m):641,214
    Market Cap:182.66M
    P/E (ttm):N/A
    EPS (ttm):-0.99
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACRX

    Comparison

    Symbol% ChgMkt Cap
    ACRXUp 2.74%182.66M
    BAXUp 3.92%21.75B
    HSPDown 0.02%15.45B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):33.53
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.74
    Quarterly EPS Est (Jun-15) :-0.26
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of acute pain. The company’s lead product candidate is Zalviso, an investigational, pre-programmed, non-invasive, handhe... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback